Showing results (651-660 of 744) with videos related to

Sort By:
Pageof 75
Genome Research|November 30, 2016
Discovery and genotyping of structural variation from long-read haploid genome sequence dataJohn Huddleston, Mark J P Chaisson, Karyn Meltz Steinberg, et al.
Annals of the American Thoracic Society|February 3, 2018
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere TrialsRuth N Moro, Nigel A Scott, Andrew Vernon, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 4, 2004
Intraoperative innominate and common carotid intervention combined with carotid endarterectomy: a "true" endovascular surgical approachDavid E Allie, Chris J Hebert, Mitchell D Lirtzman, et al.
Trials|July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
JAMA Internal Medicine|September 5, 2018
Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US HospitalLelia H Chaisson, David Duong, Adithya Cattamanchi, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 10, 2004
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experienceDavid E Allie, Chris J Hebert, Mitchell D Lirtzman, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosisSusan E Dorman, John L Johnson, Stefan Goldberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2026
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trialViolet Chihota, Zainab Waggie, Vicky Cardenas, et al.
Journal of the International AIDS Society|January 6, 2026
Characterizing tuberculosis diagnosis and the associations with economic instability and employment discrimination among women living with HIV across 11 countries in sub-Saharan Africa: a cross-sectional studyCarrie Lyons, Omar Syarif, Pim Looze, et al.
The Lancet. Infectious Diseases|September 7, 2025
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trialJohn Z Metcalfe, Isabelle R Weir, Kimberly K Scarsi, et al.
Pageof 75